share_log

6-K: Explanatory Note

6-K: Explanatory Note

6-K:解释性说明
美股SEC公告 ·  2024/09/18 20:42

Moomoo AI 已提取核心信息

Novartis Capital Corporation has announced the issuance of multi-tranche notes totaling $3.7 billion. The offering comprises four tranches: $1 billion of 3.800% Notes due 2029, $850 million of 4.000% Notes due 2031, $1.1 billion of 4.200% Notes due 2034, and $750 million of 4.700% Notes due 2054.The notes issuance is being managed by a consortium of underwriters led by Citigroup Global Markets Inc., Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, and Mizuho Securities USA LLC. The securities are being registered under Form F-3 with the SEC, with Novartis AG serving as the guarantor for these debt securities.
Novartis Capital Corporation has announced the issuance of multi-tranche notes totaling $3.7 billion. The offering comprises four tranches: $1 billion of 3.800% Notes due 2029, $850 million of 4.000% Notes due 2031, $1.1 billion of 4.200% Notes due 2034, and $750 million of 4.700% Notes due 2054.The notes issuance is being managed by a consortium of underwriters led by Citigroup Global Markets Inc., Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, and Mizuho Securities USA LLC. The securities are being registered under Form F-3 with the SEC, with Novartis AG serving as the guarantor for these debt securities.
诺华资本公司宣布发行总额为37亿的多期票据。此次发行包括四个期次:10亿的3.800%票据,2029年到期;85000万的4.000%票据,2031年到期;11亿的4.200%票据,2034年到期;以及75000万的4.700%票据,2054年到期。此次票据发行由由花旗集团全球市场公司、高盛公司、摩根大通证券公司和瑞穗证券美国公司组成的承销商联盟管理。这些证券在美国证券交易委员会的F-3表格下注册,由诺华制药作为这些债务证券的担保人。
诺华资本公司宣布发行总额为37亿的多期票据。此次发行包括四个期次:10亿的3.800%票据,2029年到期;85000万的4.000%票据,2031年到期;11亿的4.200%票据,2034年到期;以及75000万的4.700%票据,2054年到期。此次票据发行由由花旗集团全球市场公司、高盛公司、摩根大通证券公司和瑞穗证券美国公司组成的承销商联盟管理。这些证券在美国证券交易委员会的F-3表格下注册,由诺华制药作为这些债务证券的担保人。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
评论 评论 · 浏览 284

热点推荐

声明

本页的译文内容由软件翻译。Moomoo将竭力但却不能保证翻译内容之准确和可靠,亦不会承担因任何不准确或遗漏而引起的任何损失或损害。